Upcyte Technologies is a life science company specialized in the controlled, and standardization of quasi (human) primary cell products.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Hamburg
State: Hamburg
Zip:
Country: Germany
Upcyte Technologies is a life science company specialized in the controlled, and standardization of quasi (human) primary cell products. With our proprietary upcyte® technology, we are able to expand human primary cells thereby generating proliferating assay-ready cells from various human healthy or diseased tissues. The well characterized cell strains retain primary-like metabolic and physiological features as well as the typical cell-type specific morphology. upcyte® products make human primary cells accessible for meaningful standardized and cost-effective cell based assays to be used in a wide range of applications in life science research and pharmaceutical development.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2016 | Seed Round | 1 | - |
IFB Innovationsstarter IFB Innovationsstarter |
1/2016 | Seed Round | 1 | - |
IFB Innovationsstarter IFB Innovationsstarter |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|